Global Cognition and Memory Enhancement Drugs Market is Estimated to
Global Cognition and Memory Enhancement Drugs Market report published by Accurize Market Research forecast that the global market is expected to reach $5 billion by 2025; growing at a CAGR of 8.8% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.
The surge in the elderly population and an increase in the occurrence of neurological & memory-related ailments to drive the growth of the market
The surge in the elderly population and an increase in the occurrence of neurological & memory-related ailments fuel the demand for the global cognition and memory enhancement drugs market. Furthermore, increasing healthcare expenditures, benefits offered by cognitive drugs such as enhanced memory and reasoning and increasing economies also boost the growth of the market.
The global cognition and memory enhancement drugs market has been bifurcated on the basis of product type, application, and geography. The product type segment is further segmented into ADHD (attention deficit hyperactivity disorder); MPH (Methylphenidate). The application segment includes Alzheimerâ€™s disease, education sector, sports, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Ask for customization:
Author Signature :
Writer, Researcher, Digital marketer, Working in a market research firm